Hem › Äggstockscancer › Pennsylvania › Philadelphia

Kliniska studier för Äggstockscancer i Philadelphia, PA

44 studier för Äggstockscancer söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

RekryterarFas 2/3

Thomas Jefferson University Hospital, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RekryterarFas 2

Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia
och 4 fler

Alla åldrar · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekryterarFas 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Ålder 12 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RekryterarFas 1

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

Ålder 19 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06586957

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Rekryterar

University of Pennsylvania, Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05287451

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RekryterarFas 2

University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

RekryterarFas 2

Site 0232 - University of Pennsylvania, Philadelphia
Site 0178 - Thomas Jefferson University, Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

RekryterarFas 1/2

Avenzo Therapeutics Recruiting Site, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05867251

DESTINY-PANTUMOUR04

RekryterarObservationsstudie

Research Site, Philadelphia

Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

RekryterarFas 1/2

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 24 sep. 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RekryterarFas 3

University of Pennsylvania Hospital, Philadelphia
Jefferson Health Honickman Center, Philadelphia
Asplundh Cancer Pavilion, Willow Grove · 13 mi bort

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RekryterarFas 1

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

RekryterarFas 2

Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 22 sep. 2026 · NCT07059845

Prehabilitation in High-risk Oncologic Surgery

Rekryterar

Fox Chase Cancer Center - Philadelphia, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07638410

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

RekryterarFas 1/2

University of Pennsylvania, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

RekryterarFas 3

Hospital of the University of Pennsylvania ( Site 0071), Philadelphia

Ålder 18 och äldre · Kvinnor · Uppdaterad 17 sep. 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

RekryterarFas 3

Lankenau Medical Center, Wynnewood · 7 mi bort

Ålder 18 och äldre · Kvinnor · Uppdaterad 15 sep. 2026 · NCT07214779

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RekryterarObservationsstudie

University of Pennsylvania, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

RekryterarFas 1

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekryterarFas 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RekryterarFas 1

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

RekryterarFas 1

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RekryterarFas 1

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07182149

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

RekryterarObservationsstudie

ACPMP, Springfield · 8 mi bort

Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT07769346

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

RekryterarFas 3

Site 0109, Philadelphia
Site 0113, Philadelphia
Site 0114, Willow Grove · 13 mi bort

Ålder 18 och äldre · Kvinnor · Uppdaterad 12 aug. 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Rekryterar

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
Lankenau Medical Center, Wynnewood · 7 mi bort
och 5 fler

Ålder 35 till 50 · Kvinnor · Uppdaterad 7 aug. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RekryterarFas 3

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
och 5 fler

Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RekryterarFas 1/2

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT04657068